Lakefront Biotherapeutics N.V.
Bear Case (25th pct.)
97.9% vs price
Base Case (Median)
201.8% vs price
Bull Case (75th pct.)
263.3% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-25.86 | -194.0% | High (40%) |
| PE Comparable | $201.40 | 631.8% | Medium (25%) |
| Graham Number | $99.99 | 263.4% | Medium (40%) |
| EV/EBITDA | $54.47 | 97.9% | Medium (20%) |
| Earnings Power Value | $83.06 | 201.8% | Medium (50%) |
Based on 5 out of 8 methods, LKFT appears undervalued at the current price of $27.52. The base case fair value of $83.06 implies 201.8% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.